Pharmacists in New York State are invited to attend a free virtual continuing education series led by a team of multi-disciplinary experts working to end the opioid crisis in New York State. Continuing pharmacy education credits will be available.
The educational series will convene on Sunday, October 3, 2021, from 9 a.m. to 10:30 a.m. and will continue on October 17, October 24, and October 31, 2021, at that time. Participants may choose to attend any number sessions.
Topics will include: reducing overdose deaths through increasing access to naloxone; equity in access; medication for opioid use disorder; COVID-19 services; medication for addiction treatment; pharmacology, misconceptions, and myths; harm reduction; optimizing pharmacy interventions in New York State; and the legal dimensions in responding to the opioid crisis.
The educational series is co-sponsored by the National Institutes of Health HEAL Initiative Planning Committee of Cayuga, Columbia, Putnam, and Suffolk counties and the Albany College of Pharmacy and Health Sciences.
To register for any or all CEs, visit:
https://pharmacyce.acphs.edu/user/login.
The Opioid Epidemic, Impacts of COVID-19 & How Pharmacists Can Reduce Overdose Deaths Through Increasing Access to Naloxone
Speaker: Veronica Salvas, MPH, Epidemiologist, Healing Communities Study. Columbia County, NY.
UAN# 0045-9999-21-016-L01-P / 0.075 CEUs
Learning Objectives:
- Recognize the magnitude of the Opioid Epidemic and appreciate the increased risk of overdose associated with the COVID-19 pandemic nationally and within NY State.
- Recall temporal and geographic trends in naloxone dispensing via pharmacies and appreciate the need for increased access to naloxone, particularly in suburban and rural communities.
- Review consumer reported barriers to accessing naloxone via pharmacy dosing data from NEXT Distro, a web and mail-based harm reduction and naloxone distribution program.
- Consider ways pharmacists can use a Harm Reduction approach to increase access to naloxone through lessening the impacts of reported barriers; lack of transportation to the pharmacy, high cost of naloxone, lack of awareness of where to access naloxone, and stigma against people who use drugs.
Equity in Access: Naloxone, MOUD, & Covid 19 Services
Speaker: Dr. Dawn Goddard-Eckrich, Ed.D., Associate Research Scientist, School of Social Work, Columbia University.
UAN# 0045-9999-21-017-L01-P / 0.075 CEUs
Learning Objectives:
- Describe how disparities around MOUD, naloxone, Covid-19 testing and vaccine at the pharmacy level.
- Recognize the role pharmacy policies have in contributing to stigma and barriers to opioid treatment and engagement (i.e., space, stocking, ID's, advertising, training) and importance of using non-stigmatizing language when interacting with colleagues and patients.
- Recall Group Model Building (GMB) and how this community engagement approach and data can be used to reduce the disparities.
- Review pharmacy and pharmacist's role to reduce health disparities and support overdose prevention.
To register, visit: https://pharmacyce.acphs.edu/user/login
UPCOMING SESSIONS:
Sunday, October 17, 2021, 9 to 10:30 a.m. -- Medication For Addiction Treatment: Pharmacology, Misconceptions, and Myths
Sunday, October 24, 2021, 9 to 10:30 a.m. -- 1) Harm Reduction for Pharmacists -- 2) Optimizing Pharmacy Interventions in New York State
Sunday, October 31, 2021, 9 to 10:30 a.m. -- Response to the Opioid Crisis: Legal Dimensions & Harm Reduction
See the Suffolk County Department of Health Services calendar for more information on upcoming sessions. https://www.suffolkcountyny.gov/health
Live On-line Webinar: Attendees who register for remote viewing will receive a link to attend the program using their computer, tablet or phone, along with instructions to access Zoom Meeting one week prior to the webinar. You will be able to listen to the speakers and view the educational materials and respond to polling questions. In order to qualify as a live activity, questions may be posed to the presenters by means of the on-line chat function.
Continuing Education: Continuing Education credit has been approved for up to 6 live Continuing Education Units (CEUs) or 0.6 Contact Hours of live Continuing Education. Participants must log in using your full name so that proof of participation can be confirmed. Participants must also complete the online learning assessments for the activity attended after the program to receive credit for this activity. You will have 45 days from the day of the program to complete the evaluations and learning assessments to receive ACPE credit. Upon completion and verification, your continuing pharmacy education credits will be sent to CPE Monitor. Statements of credit may be printed from the CPE Monitor website at: www.nabp.net/pharmacists.
ACPE policy states that paper and/or electronic statements of credit are no longer required to be distributed directly to learners as proof of ACPE credit. This official record of credit is located on the learner's e-profile in CPE Monitor. Printed copies of statements will no longer be distributed by Albany College of Pharmacy and Health Sciences.
Registration Fee: There is not a fee to attend this Continuing Education Program. However, registration is required in order for us to send you the program handouts and Zoom Meeting link. The deadlines to register for each session are as follows:
- Friday, October 1: The Opioid Epidemic, Impacts of COVID-19 & How Pharmacists Can Reduce Overdose Deaths Through Increasing Access to Naloxone and Equity in Access: Naloxone, MOUD, & Covid 19 Services
- Friday, October 15: Medication For Addiction Treatment: Pharmacology, Misconceptions, and Myths
- Friday, October 22: Harm Reduction for Pharmacists and Optimizing Pharmacy Interventions in New York State
- Friday, October 29: Response to the Opioid Crisis: Legal Dimensions & Harm Reduction
Register by visiting: https://pharmacyce.acphs.edu/user/login.
Statement of Disclosure: In accordance with ACPE Standards, ACPHS requires that speakers and program planners disclose any relationships that they may have with commercial interests whose products or services may be mentioned in their presentations. All speakers and program planners involved in this series have no disclosures or conflicts of interest.